Federal contractors / CERUS CORPORATION

Federal contract award

75F40120C00158

BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST NO FEE
Obligations$11.1M
Current contract value$11.1M
Potential contract value / ceiling$11.1M
Start dateSep 24, 2020
Current end dateSep 28, 2025
Potential end dateSep 28, 2025
Latest award activityJul 24, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 24, 2025P00004$0BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD, COR CHANGE

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Christine RussmanContactChristine.Russman@fda.hhs.gov
3017967841		SourceJan 17, 2020
Richard RobinsonContactRichard.Robinson@fda.hhs.gov
301-796-6508		SourceJan 17, 2020
Christine RussmanContactChristine.Russman@fda.hhs.gov
3017967841		SourceJan 17, 2020
Richard RobinsonContactRichard.Robinson@fda.hhs.gov
301-796-6508		SourceJan 17, 2020

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.